The American Journal of Gastroenterology · 2015 · 50 citations · 22 references
MedicinePathologyCancer EpidemiologyDisease SurveillanceEpidemiologyCancer Early DetectionCancer RegistriesColonic DiseasesColorectal SurgeryGenetic Risk AssessmentPopulation ScreeningColorectal Cancer PrevalenceColorectal Cancer ScreeningMicrosatellite Instability AnalysisMicrosatellite Instability AssaysMicrosatellite Instability DetectionMicrosatellite Instability In Colorectal CancerMicrosatellite Instability In Hereditary Cancer SyndromesMicrosatellite Instability Testing
OBJECTIVES: As there are no US population-based studies examining Lynch syndrome (LS) screening frequency by microsatellite instability (MSI) and immunohistochemistry (IHC), we seek to quantitate statewide rates in patients aged ≤50 years using data from a Centers for Disease Control and Prevention-funded Comparative Effectiveness Research (CER) project and identify factors associated with testing. Screening rates in this young, high-risk population may provide a best-case scenario as older patients, potentially deemed lower risk, may undergo testing less frequently. We also seek to determine how frequently MSI/IHC results are available preoperatively, as this may assist with decisions regarding colonic resection extent. METHODS: Data from all Louisiana colorectal cancer (CRC) patients aged ≤50 years diagnosed in 2011 were obtained from the Louisiana Tumor Registry CER project. Registry researchers and physicians analyzed data, including pathology and MSI/IHC. RESULTS: Of the 2,427 statewide all-age CRC patients, there were 274 patients aged ≤50 years, representing health care at 61 distinct facilities. MSI and/or IHC were performed in 23.0% of patients. Testing-associated factors included CRC family history (P<0.0045), urban location (P<0.0370), and care at comprehensive cancer centers (P<0.0020) but not synchronous/metachronous CRC or MSI-like histology. Public hospital screening was disproportionately low (P<0.0217). Of those tested, MSI and/or IHC was abnormal in 21.7%. Of those with abnormal IHC, staining patterns were consistent with LS in 87.5%. MSI/IHC results were available preoperatively in 16.9% of cases. CONCLUSIONS: Despite frequently abnormal MSI/IHC results, LS screening in young, high-risk patients is low. Provider education and disparities in access to specialized services, particularly in underserved populations, are possible contributors. MSI/IHC results are infrequently available preoperatively.
22
Michelle Landon, Jennifer Saam, Krystal Brown et al. · Oncology · 2015 · 1.9K citations · Full text
Life Sciences, Genetics, Oncology +17